Healthcare provider profile · identity verified

Michelle Cutler, APRN

Nurse Practitioner · WALPOLE, NH · NPI 1841643384

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	134
Losartan Potassium	Losartan Potassium	369	104
Rosuvastatin Calcium	Rosuvastatin Calcium	323	90
Levothyroxine Sodium	Levothyroxine Sodium	315	84
Amlodipine Besylate	Amlodipine Besylate	300	78
Omeprazole	Omeprazole	292	97
Lisinopril	Lisinopril	280	79
Metoprolol Succinate	Metoprolol Succinate	225	56
Hydrochlorothiazide	Hydrochlorothiazide	197	50
Oxycodone Hcl	Oxycodone Hcl	151	21
Trazodone Hcl	Trazodone Hcl	146	36
Tamsulosin Hcl	Tamsulosin Hcl	142	47
Gabapentin	Gabapentin	137	39
Furosemide	Furosemide	130	41
Escitalopram Oxalate	Escitalopram Oxalate	122	27
Metoprolol Tartrate	Metoprolol Tartrate	114	31
Albuterol Sulfate Hfa	Albuterol Sulfate	107	46
Alprazolam	Alprazolam	103	28
Lorazepam	Lorazepam	103	29
Pantoprazole Sodium	Pantoprazole Sodium	97	33
Metformin Hcl Er	Metformin Hcl	95	31
Temazepam	Temazepam	89	suppressed
Allopurinol	Allopurinol	82	23
Famotidine	Famotidine	82	29
Venlafaxine Hcl Er	Venlafaxine Hcl	74	14
Zolpidem Tartrate	Zolpidem Tartrate	73	16
Simvastatin	Simvastatin	70	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	70	12
Prednisone	Prednisone	68	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	23
Eliquis	Apixaban	66	26
Pravastatin Sodium	Pravastatin Sodium	63	14
Citalopram Hbr	Citalopram Hydrobromide	60	18
Metformin Hcl	Metformin Hcl	60	16
Pregabalin	Pregabalin	60	suppressed
Sertraline Hcl	Sertraline Hcl	60	20
Fluticasone Propionate	Fluticasone Propionate	59	29
Bupropion Xl	Bupropion Hcl	58	17
Morphine Sulfate	Morphine Sulfate	57	suppressed
Clopidogrel	Clopidogrel Bisulfate	56	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	56	suppressed
Clonazepam	Clonazepam	55	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	52	14
Morphine Sulfate Er	Morphine Sulfate	50	suppressed
Potassium Chloride	Potassium Chloride	49	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	48	suppressed
Synthroid	Levothyroxine Sodium	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	14
Ibuprofen	Ibuprofen	44	11
Jardiance	Empagliflozin	41	12
Esomeprazole Magnesium	Esomeprazole Magnesium	40	15
Tramadol Hcl	Tramadol Hcl	40	12
Glipizide	Glipizide	39	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	24
Spironolactone	Spironolactone	33	suppressed
Ezetimibe	Ezetimibe	32	11
Meloxicam	Meloxicam	32	12
Doxycycline Hyclate	Doxycycline Hyclate	31	29
Azithromycin	Azithromycin	30	25
Celecoxib	Celecoxib	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	19
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	25	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Ozempic	Semaglutide	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Xarelto	Rivaroxaban	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Varenicline Tartrate	Varenicline Tartrate	21	suppressed
Digoxin	Digoxin	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Methylphenidate Er	Methylphenidate Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	15
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Ondansetron Odt	Ondansetron	15	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Finasteride	Finasteride	14	suppressed
Methylphenidate Hcl Er (Cd)	Methylphenidate Hcl	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Valsartan	Valsartan	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Baclofen	Baclofen	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diazepam	Diazepam	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error